Zaloguj Zarejestruj się zadarmo

RepliCel Life Sciences organizacji Marża brutto

Jaka jest wartość Marża brutto organizacji RepliCel Life Sciences?

Wartość Marża brutto organizacji RepliCel Life Sciences, Inc. to 100.00%

Jaka jest definicja Marża brutto?



Marża brutto to różnica między przychodem a kosztem sprzedaży towarów podzielona przez przychód i wyrażona w procentach.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Marża brutto firm w Health Care sektor na TSXV w porównaniu do RepliCel Life Sciences

Czym się zajmuję organizacja RepliCel Life Sciences?

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.

Firmy z marża brutto podobne do RepliCel Life Sciences